Bio-Based, Renewable & Platform Chemicals Advisory
Technical and investment due diligence for investors and corporates backing renewable chemicals on the move from pilot to commercial scale.
Trident Renewables provides technical due diligence and investment due diligence on bio-based chemicals, also called renewable chemicals, including the platform chemicals that polymers and materials are built from. We advise private equity, infrastructure funds, DFIs and corporate strategics deciding whether a molecule can move from pilot to commercial scale and still earn a return.
The sector sits where PtL e-fuels and e-SAF were a few years ago. The chemistry works in the pilot plant. The open question is whether the first commercial plant holds its yield and its customers once capital is committed. That is a scale-up and commercialization feasibility question, and it is where the best-known bio-based chemical failures happened, after the science was proven.
Buy-side only: no sell-side mandates
20+ facilities across pilot, scale-up and commercial operation
3 expert reports and 2 depositions in chemical, carbon finance and bioplastics disputes
Decisions We Support
Clients bring us a decision with capital attached. The question changes with who is asking.
Private equity and infrastructure GPs: platform acquisitions, growth equity and buy-and-build in bio-based producers, where the investment case depends on a plant reaching nameplate.
LPs: stress-testing a GP's renewable chemicals thesis before a fund commitment, or a co-investment alongside it.
DFIs and project lenders: underwriting first-of-a-kind (FOAK) plants, where the lender carries scale-up risk the sponsor's model may not price.
Corporate strategics: make, buy or partner decisions, technology licensing, and multi-year offtake or supply agreements.
Boards: approving capex for a commercial plant, or challenging management's commercialization case before it goes to market.
Our View: Where Bio-Based Chemicals Are Investable
Bio-based chemicals are investable at two ends and risky in the middle. One end is the producer with the lowest-cost integrated feedstock. The other is a material with a property the incumbent cannot match, so the buyer pays for performance. Producers in between depend on the oil price and a green premium, and either can disappear.
Our cost-curve work puts numbers on this. With a $250 per tonne green premium, integrated sugarcane bio-ethylene breaks even near $69 Brent, the corn route near $99 and merchant ethanol near $117. The technology is identical across all three. Feedstock position decides who survives a fall in oil.
Read the full platform chemicals cost-curve analysis and our view on drop-in versus dedicated renewable materials.
Renewable Chemicals and Platform Chemicals We Cover
Each class carries a different risk, so the tests change with the molecule.
Drop-In Commodity Chemicals
Molecules: bio-ethylene, bio-MEG, bio-MPG, bio-BDO, bio-methanol, bio-naphtha.
What we test: feedstock cost against the fossil incumbent, how long the green premium holds, and mass-balance certification.
Status, October 2026: commercial. Braskem produces bio-PE in Brazil; Qore produces bio-BDO at 66,000 t/yr in Eddyville, Iowa.
Organic Acids and Oxidants
Molecules: lactic, succinic, itaconic, adipic, gluconic and glucaric acids; hydrogen peroxide.
What we test: titer, yield and productivity at scale; purification cost; whether the molecule replaces an incumbent or serves a niche.
Status, October 2026: mixed. Solugen produces hydrogen peroxide and organic acids by a chemoenzymatic route. The first succinic acid wave failed with BioAmber. Itaconic acid is a partial substitute for acrylic acid in selected formulations.
Biopolymers and Renewable Materials
Molecules: PLA, PHA, PEF and its monomer FDCA.
What we test: the property advantage a buyer will pay for, converter qualification time, and end-of-life claims under real composting conditions.
Status, October 2026: PLA is commercial (NatureWorks in Nebraska and Thailand; TotalEnergies Corbion in Thailand). PHA runs at small scale with unproven economics. FDCA is in start-up at Avantium, Delfzijl.
Aviation and Elastomer Intermediates
Molecules: farnesene and farnesane, isobutanol, monoterpenes (pinene, limonene), bio-isoprene.
What we test: ASTM D7566 annex status and blend limits, dual fuel and chemical offtake, and exposure to fuel credits.
Status, October 2026: farnesane is certified under Annex A3 at a 10% blend limit; isobutanol-to-jet is certified under Annex A5. Producer economics are unproven after Amyris. Isoprene and terpene routes are pre-commercial.
Lignocellulosic and Waste-Biomass Platforms
Molecules: levulinic acid and derivatives, residue-derived sugars.
What we test: pretreatment cost, feedstock logistics, impurity handling and by-product value.
Status, October 2026: demonstration to early commercial.
CO2-Derived Chemicals
Molecules: e-methanol, formic acid.
What we test: electrolytic hydrogen cost, CO2 source and lifecycle accounting. Low-carbon is defensible; carbon-negative rarely is.
Status, October 2026: pilot to early commercial. Economics track green hydrogen cost.
Status reflects Trident's assessment as of October 2026. For jet pathways, see our SAF project advisory.
How We Assess a Bio-Based Chemicals Opportunity
Every mandate runs through six tests. The weight of each depends on the molecule and the decision in front of you.
Feedstock position. Is the feedstock owned, contracted or bought on spot? That decides where the producer sits on the cost curve against the fossil incumbent.
Scale-up evidence. Which pilot and demonstration results support the commercial design basis, and which are extrapolated? Our chemical engineering scale-up diligence covers kinetics, balances and start-up readiness in depth.
Product qualification. Is the molecule a drop-in replacement, or a new specification the buyer must approve? Qualification can take longer than construction.
Premium and offtake durability. Does the business still work with half its green premium, or none? Are the offtakes take-or-pay contracts or memoranda of understanding?
Certification and policy fit. Which certification does the buyer require? The usual options are ISCC PLUS mass balance, USDA BioPreferred, or measured bio-based content under ASTM D6866 or EN 16785. Fuel-only credits such as 45Z, LCFS and RINs are flagged as fuel-only.
FOAK capital risk. Is the first commercial plant funded through a realistic ramp? Avantium guides roughly 24 months from start-up to full design capacity at its Delfzijl FDCA plant. We use that as a reference for how long a first-of-a-kind balance sheet has to last.
Engagements and Deliverables
A red-flag review typically takes two to three weeks from data room access. Trident works for buyers only and has never taken a sell-side mandate, so the conclusions answer to the investor or corporate making the decision.
Investment due diligence: an IC-ready memo with a risk-ranked view of the case, red flags, and the conditions under which we would support it.
Technical due diligence: independent review of process data, design basis and scale-up assumptions, separating demonstrated performance from extrapolation.
Commercialization feasibility: a cost model built from yield, feedstock, energy and capex, tested against the fossil incumbent and a realistic green premium.
Technology and route screening: competing routes to the same molecule compared on one cost basis, before a licensing or partnering decision.
Market and offtake validation: buyer demand, qualification timelines and contract quality behind the revenue line.
Portfolio and pipeline review: for funds and corporates holding several molecules, a view on which to keep funding and which to exit.
Expert witness support: expert reports and depositions in chemical, carbon finance and bioplastics disputes, through our chemical engineering practice.
Who Leads This Work
Trident's renewable chemicals advisory is led by Gaurav Shah, Managing Partner. He is a chemical engineer (M.S., University of Southern California) with more than 20 years as an investor and operating partner. He built and ran industrial biofuel plants in the US, and led M&A and turnarounds of renewable energy assets as a partner at a San Francisco private equity firm. He sits on investment committees for venture, private equity and hedge funds in the US and India.
Six US patents and one PCT patent in waste-to-biofuel conversion.
Expert report in a chemical-sector dispute, after which 45% of the disputed claims were dropped.
Supported a venture investor's decision to back a bio-based chemicals platform that has since scaled its production.
Advised investors to pass on a biopolymer producer whose scale-up case did not hold. The company later failed.
Renewable and Platform Chemicals Due Diligence: Key Questions
What does bio-based chemicals due diligence cover?
Bio-based chemicals due diligence tests whether a renewable chemical can reach commercial scale and earn a return. Trident Renewables covers technical due diligence on yield, scale-up and design basis, and investment due diligence on feedstock cost, green premium, offtake quality, certification and first-plant funding.
How does Trident assess commercialization feasibility for a pilot-stage renewable chemical?
Trident rebuilds the commercial cost case from pilot data: yield, titer, feedstock, energy and capex. Then we test it against the fossil incumbent's price, a halved green premium and a realistic first-plant ramp. If the case only works at nameplate from day one, or above $90 oil, it is not yet investable.
Which bio-based chemicals are commercially proven?
As of October 2026, bio-based polyethylene (Braskem), PLA (NatureWorks and TotalEnergies Corbion) and bio-BDO (Qore's 66,000-tonne Eddyville plant) run at commercial scale. FDCA for PEF entered start-up at Avantium's Delfzijl plant in 2026. Most other organic acids, PHA and CO2-derived chemicals remain at early commercial scale or earlier.
Why do bio-based chemical companies fail after reaching production?
Usually for commercial reasons. BioAmber, an early commercial producer of bio-succinic acid, went bankrupt in 2018. Amyris filed for Chapter 11 in 2023 after years of cash burn. Danimer Scientific filed in 2025 under liquidity pressure and project delays. Viridis paused a nearly finished ethyl acetate plant as demand weakened and tariffs raised costs.
Which incentives apply to renewable chemicals?
Far fewer than fuels receive. US 45Z, state LCFS programs, RFS RINs and EU ReFuelEU reward transport fuels only, and CBAM does not currently cover organic chemicals. What moves chemical buyers is certification such as ISCC PLUS and USDA BioPreferred, plus the EU Bioeconomy Strategy's lead-market measures, including planned bio-based plastics targets.
How long does a bio-based chemicals red-flag review take?
A red-flag review typically takes two to three weeks from data room access. Trident Renewables works for buyers only and has never taken a sell-side mandate, so the findings answer to the investor or corporate making the decision.
Last reviewed: October 2026
Discuss a Bio-Based Chemicals Mandate
Share the investment memo, deck or data room scope, with the decision and timeline you are working to. We reply with a proposed scope and the first questions we would test.